NCT03056729View on ClinicalTrials.gov

Single-Ascending-Dose Study of BIIB076 in Healthy Volunteers and Participants With Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

February 17, 2017

Primary Completion Date

March 3, 2020

Study Completion Date

March 3, 2020

Conditions
Alzheimer's DiseaseHealthy Volunteer
Interventions
DRUG

BIIB076

Administered as single intravenous (IV) infusion

DRUG

Placebo

Administered as single IV infusion

Trial Locations (8)

32127

Progressive Medical Research, Port Orange

32806

Bioclinica Research, Orlando

33009

MD Clinical, Hallandale

46202

Indiana University, Indianapolis

53704

Covance CRU, Madison

63141

St Louis Clinical Trial, St Louis

75247

Covance Dallas CRU, Dallas

96817

Hawaii Pacific Neuroscience, Honolulu

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY